Nevertheless, the present observation, while acknowledging the possibility of a coincidental relationship between ependymoma and POLR2A variant, suggests adding POLR2A to the list of genes to include in oncopediatric next‐generation sequencing panels, especially for patients with ependymoma associated with developmental delay, malformations, and facial anomalies. The gene discussed is POLR2A; the disease is ependymoma.